ES2177755T3 - Nuevos preparados farmaceuticos a base de peptido de activacion de proteina c. - Google Patents

Nuevos preparados farmaceuticos a base de peptido de activacion de proteina c.

Info

Publication number
ES2177755T3
ES2177755T3 ES96901265T ES96901265T ES2177755T3 ES 2177755 T3 ES2177755 T3 ES 2177755T3 ES 96901265 T ES96901265 T ES 96901265T ES 96901265 T ES96901265 T ES 96901265T ES 2177755 T3 ES2177755 T3 ES 2177755T3
Authority
ES
Spain
Prior art keywords
protein
activation peptide
pharmaceutical preparations
new pharmaceutical
preparations based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96901265T
Other languages
English (en)
Inventor
Johann Eibl
Ludwig Pichler
Hans-Peter Schwarz
Peter Turecek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter AG
Original Assignee
Baxter AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter AG filed Critical Baxter AG
Application granted granted Critical
Publication of ES2177755T3 publication Critical patent/ES2177755T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE PRESENTA EL USO DEL PEPTIDO DE ACTIVACION DE LA PROTEINA C PARA PREPARAR UNA PREPARACION FARMACEUTICA QUE POSEE UNA ACTIVIDAD ANTINOCICEPTIVA. ESTA PREPARACION FARMACEUTICA ES UTIL EN EL TRATAMIENTO DE ESTADOS DOLOROSOS PROVOCADOS POR PROCESOS INFLAMATORIOS AGUDOS O CRONICOS (TALES COMO ARTRITIS REUMATOIDEA, MIOSITIS, GASTRITIS, COLITIS, INFLAMACIONES EN EL TRACTO UROGENITAL).
ES96901265T 1995-01-20 1996-01-12 Nuevos preparados farmaceuticos a base de peptido de activacion de proteina c. Expired - Lifetime ES2177755T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/375,777 US5571786A (en) 1990-08-16 1995-01-20 Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation

Publications (1)

Publication Number Publication Date
ES2177755T3 true ES2177755T3 (es) 2002-12-16

Family

ID=23482293

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96901265T Expired - Lifetime ES2177755T3 (es) 1995-01-20 1996-01-12 Nuevos preparados farmaceuticos a base de peptido de activacion de proteina c.

Country Status (9)

Country Link
US (1) US5571786A (es)
EP (1) EP0804228B1 (es)
JP (1) JP3330953B2 (es)
AT (2) ATE218368T1 (es)
CA (1) CA2209931A1 (es)
DE (1) DE69621591T2 (es)
DK (1) DK0804228T3 (es)
ES (1) ES2177755T3 (es)
WO (1) WO1996022108A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001526533A (ja) * 1997-04-23 2001-12-18 フラームス・インテルウニフェルシタイル・インスティチュート・フォール・ビオテヒノロヒー λ様プロモーターを有する遺伝子の誘導性発現のための調節系
US6953568B1 (en) * 1998-08-25 2005-10-11 Oklahoma Medical Research Foundation Targeting of molecules to large vessel endothelium using EPCR
WO2000037022A2 (en) * 1998-12-21 2000-06-29 Eli Lilly And Company Combination therapy for the treatment of sepsis
JP2004503216A (ja) * 2000-05-22 2004-02-05 ジョンズ・ホプキンス・ユニバーシティ 疾患を阻止するための血管移植片の遺伝子工学処理
AU2002302192B2 (en) * 2001-06-13 2007-08-16 Zz Biotech Llc Treatment and composition for wound healing
AU2002354951A1 (en) * 2001-07-19 2003-03-03 Dmi Biosciences, Inc. Use of copper chelators to inhibit the inactivation of protein c
CN1980948B (zh) 2002-11-27 2011-08-10 Dmi生物科学公司 治疗由增强磷酸化介导的疾病和病况
IN2014DN10075A (es) 2012-05-31 2015-08-21 Univ Kinki
WO2014005183A1 (en) 2012-07-04 2014-01-09 The University Of Sydney Treatment of inflammatory skin disorders
EP3137102B1 (en) 2014-04-16 2021-07-14 ZZ Biotech LLC Apc for use in the treatment of abnormal cutaneous scarring
US11497795B2 (en) 2018-09-28 2022-11-15 Asahi Kasei Pharma Corporation Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
GB8319538D0 (en) * 1983-07-20 1983-08-24 Beecham Group Plc Compounds
US4658830A (en) * 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
US4902614A (en) * 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
US4849403A (en) * 1985-05-29 1989-07-18 Pentapharm Ag Protein C activator, methods of preparation and use thereof
US4908314A (en) * 1987-07-02 1990-03-13 American National Red Cross Protein C activator
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
US5009889A (en) * 1987-12-31 1991-04-23 Oklahoma Medical Research Foundation Treatment of dysfunctional vascular endothelium using activated protein C
JP2739050B2 (ja) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 抗血液凝固剤
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
US5093117A (en) * 1989-01-24 1992-03-03 Baxter International Inc. Compositions and method for the treatment or prophylaxis of sepsis or septic shock
JP2774156B2 (ja) * 1989-09-05 1998-07-09 帝人株式会社 ヒトプロテインｃおよび／または活性化ヒトプロテインｃ様活性を有する蛋白
AT402260B (de) * 1990-08-16 1997-03-25 Immuno Ag Protein c-hältige pharmazeutische präparation

Also Published As

Publication number Publication date
DE69621591D1 (de) 2002-07-11
DE69621591T2 (de) 2003-01-16
DK0804228T3 (da) 2002-09-23
JP3330953B2 (ja) 2002-10-07
US5571786A (en) 1996-11-05
ATA901196A (de) 2002-04-15
WO1996022108A1 (en) 1996-07-25
EP0804228B1 (en) 2002-06-05
EP0804228A1 (en) 1997-11-05
ATE218368T1 (de) 2002-06-15
JPH11502508A (ja) 1999-03-02
CA2209931A1 (en) 1996-07-25
AT409822B (de) 2002-11-25

Similar Documents

Publication Publication Date Title
DE69104777T2 (de) Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
UA43348C2 (uk) Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад
ATE133181T1 (de) Dehydrodidemnin b
ES2229045T3 (es) Derivados de peptidos terapeuticos.
FR2695714B1 (fr) Installation de traitement cryogénique, notamment de distillation d'air.
ES2177755T3 (es) Nuevos preparados farmaceuticos a base de peptido de activacion de proteina c.
DK289285A (da) Thymopentin analoge
ZA963826B (en) A method of treatment of mania and bipolar disorder
FR2694296B1 (fr) Peptides inhibant l'activité des protéines ras, préparation et utilisation.
DE59410132D1 (de) Humanes zirkulierendes cytokin cc-1
NO980296L (no) Forbedrede terapeutiske midler
AU6804394A (en) Oral pharmaceutical compositions comprising a protein or peptide, an antibody and polymeric beads
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
TR199600583A2 (tr) Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi.
CA2041380A1 (en) Use of protein c or activated protein c for preparing a pharmaceutical preparation
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
CA2316447A1 (en) Rantes mutants and therapeutic applications thereof
AU6700996A (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
AU580890B2 (en) P-acylaminobenzamides
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
DE3782199D1 (de) Biologisch aktive peptide tan-866.
DE59610098D1 (de) Protein mit anti-tumorwirkung
NZ505580A (en) Method of treating immunodeficiences using neutrokine alpha
DE59609353D1 (de) Mittel zur subkutanen Verabreichung von Protein C
RU93005016A (ru) Иммунорегуляторные и нейрорегуляторные пентапептиды, фармацевтические композиции на их основе, способ получения пентапептидов, способ лечения